# Top 50 Medical Startup Investors in Asia in June 2026 ## HSG - Type: VC Fund - Location: Beijing, Beijing, China - Relevant deals: 34 - Stages: Series A, Series B, Series C - Focus: Health Care, Biotechnology, Software We help founders build enduring companies. ## BioVenture - Type: VC Fund - Location: Suzhou, Jiangsu, China - Relevant deals: 34 - Stages: Series A, Series B, Seed - Focus: Health Care, Medical, Biotechnology Suzhou Industrial Park Bioventure Investment Management Limited (Bioventure) was established in September 2013. Bioventure its first element of the new bio-industry funds 540 million yuan fund size. Bioventure specialize in the field of life sciences in the early stages of the venture capital investments as having high strength and growth, greaterdevelopment space, excellent management team, biotechnology, drug discovery, medical devices and healthcare services companies, and provide capital, management , operation and other aspects of post-investment support and services.Bioventure brought together senior investment professionals team with bio-pharmaceutical industry investment experience, strong fund management, entrepreneurship and venture capital and operating experience in business, have a deep understanding of the domestic and foreign markets, capable of its forward-looking international perspective and extensive The industry has the potential resources to help innovative companies grow rapidly and gain greater success, while giving fund investors bring considerable returns.Suzhou Industrial Park, the core investor BioBay has the country's best medical and pharmaceutical incubator function, use the platform, the project team has great resources and industrial service advantages, Yuan-sheng venture has successfully invested in 20 projects have been cast projects in their own development and follow-up financing, has made outstanding achievements in the industry for all to see, and won the Venture's trust and praise.By focusing and extensive industry resources, Bioventure determined to become one of China's most successful medical and pharmaceutical venture fund. Bioventure expectations and in the medical and pharmaceutical industry where there joint venture development cooperation. ## Qiming Venture Partners - Type: VC Fund - Location: Shanghai, Shanghai, China - Relevant deals: 31 - Stages: Series B, Series A, Series C - Focus: Health Care, Biotechnology, Medical Founded in 2006, Qiming Venture Partners is a leading China venture capital firm with offices in Shanghai, Beijing, Suzhou, Hong Kong in China, and Singapore.Currently, Qiming Venture Partners manages eleven US Dollar funds and seven RMB funds with $9.5 billion in capital raised. Since our establishment, we have invested in outstanding companiesin the Technology and Consumer (T&C) and Healthcare industries at the early and growth stages.Since our debut, we have backed over 530 fast-growing and innovative companies. Over 200 of our portfolio companies have achieved exits through IPOs at the NYSE, NASDAQ, HKEX, Shanghai Stock Exchange, or Shenzhen Stock Exchange, or through M&A or other means. There are also over 70 portfolio companies that have achieved unicorn or super unicorn status. ## Med-Fine Capital - Type: VC Fund - Location: Shanghai, Shanghai, China - Relevant deals: 26 - Stages: Series A, Seed, Series B - Focus: Medical, Health Care, Biotechnology Med-Fine Capital is a venture capital firm focusing on early stage investments in China healthcare industry. The company is headquartered in Shanghai with offices in Beijing and Shenzhen. ## Legend Capital - Type: VC Fund - Location: Beijing, Beijing, China - Relevant deals: 24 - Stages: Series B, Series A, Series C - Focus: Health Care, Medical, Biotechnology Legend Capital, a subsidiary of Legend Holdings Ltd., started its vintage year in April, 2001 with a mission to become a top-notch and the most respected venture capital investment manager in China.Managing up to US$700 million across four funds, Legend Capital focuses on driving high-growth ventures with operations substantially based in Chinaor on markets related to China.Legend Capital mainly invests in early stage IT companies, specifically, in sectors of network applications and services, outsourcing and professional services, Infrastructure (IC design/key components), and mid-market growth stage companies in the fields of consumer goods, clean technology, health care, equipment manufacturing and modern services.Among over 60 portfolio companies are Joyo.com (acquired by Amazon.com), SinoCom (0299.HK), Solarfun Power (Nasdaq: SOLF), Spreadtrum Communications (Nasdaq: SPRD), China Sunshine Paper (2002.HK), and VanceInfo (NYSE:VIT), Eyang (0117.HK), etc.As an active investor, Legend Capital provides its portfolio companies extensive business resources and tailored services to assist with business development, company image building, and other critical company building activities on Chinese market so as to add value and maximize returns. Legend Capital is proud and thankful that it has the opportunity to blaze a trail with its innovative practice for China's venture capital industry. ## Shanghai Biomedical Industrial Equity Investment Fund - Type: VC Fund - Location: Huangpu, Shanghai, China - Relevant deals: 20 - Stages: Series A, Seed, Series B - Focus: Health Care, Medical, Biotechnology Shanghai Biomedical Industrial Equity focuses on areas that are in line with the development strategy of the biomedical industry. ## Frees Fund - Type: VC Fund - Location: Beijing, Beijing, China - Relevant deals: 20 - Stages: Series A, Seed, Angel - Focus: Artificial Intelligence, Health Care, Biotechnology By adopting revolutionary mechanisms, FREES FUND is devoted to change the long-established rules in the venture capital. By leveraging the cutting-edge technologies and resources, FREES FUND aims at investing in great startups and helping them grow into great enterprises that are valuable to our society. We mainly invest in early-stagestartups, and hope to become their first-round institutional investor. Our primary interested areas are broad-sense TMT (Technology, Media, Telecom), B2B and deep technology. ## Marathon Venture Partners - Type: VC Fund - Location: Shanghai, Shanghai, China - Relevant deals: 20 - Stages: Series A, Series B, Seed - Focus: Health Care, Medical, Biotechnology Marathon Venture Partners is an international VC fund that focuses on early and growth stage companies in healthcare and Fintech industry. ## Mitsubishi UFJ Capital - Type: VC Fund - Location: Tokyo, Tokyo, Japan - Relevant deals: 19 - Stages: Series A, Series B - Focus: Information Technology, Software, Health Care Mitsubishi UFJ Capital is a venture capital firm focusing on life science, ICT, and high technology investments. ## Cowin Venture - Type: VC Fund - Location: Beijing, Beijing, China - Relevant deals: 18 - Stages: Series A, Angel, Series B - Focus: Health Care, Medical, Biotechnology Founded in 2009, Cowin Venture is an angel and early-stage investor in TMT and Healthcare. We keep nurturing growth-stage companies graduated from their angel investment portfolio. Cowin’s business network covers China and USA. They have offices in Suzhou, Nanjing, Shanghai, Beijing and Hong Kong. ## Prox Ventures - Type: VC Fund - Location: Shanghai, Shanghai, China - Relevant deals: 17 - Stages: Seed, Series A - Focus: Medical, Biotechnology, Health Care Proxima Ventures focuses in the healthcare industry, supporting outstanding enterprises with innovative technologies or service models that have tremendous potential.They manage multiple funds in RMB and US dollar, covering from seed to growth stages. Their team members with multidisciplinary backgrounds and resourceful networks, have many yearsof remarkable venture capital experience and achievements. They believe that active and effective collaboration with entrepreneurs will make substantial economic returns while bring meaningful improvements in public health. ## Lilly Asia Ventures - Type: VC Fund - Location: Shanghai, Shanghai, China - Relevant deals: 17 - Stages: Series A, Series B, Series C - Focus: Biotechnology, Health Care, Medical Lilly Asia Ventures (LAV) is a leading biomedical venture capital firm headquartered in China, with offices in Shanghai, Hong Kong, and Palo Alto. ## ANRI - Type: VC Fund - Location: Tokyo, Tokyo, Japan - Relevant deals: 17 - Stages: Seed, Series A - Focus: Software, Health Care, Information Technology ANRI is a Japanese venture capital firm that mainly invests in seed and early-stage startups. ## Puhua Capital - Type: VC Fund - Location: Hangzhou, Zhejiang, China - Relevant deals: 17 - Stages: Series A, Series B, Seed - Focus: Health Care, Medical, Manufacturing Puhua Capital is an equity investment firm that focuses on early and middle project. Puhua Capital provides the required resources and management experience for the invested enterprise, investing funds and more resources and wisdom. Puhua Capital has invested nearly 300 excellent start-ups. ## Fast Track Initiative, Inc. - Type: VC Fund - Location: Hongo, Tokyo, Japan - Relevant deals: 16 - Stages: Series A, Seed, Series B - Focus: Health Care, Biotechnology, Medical Fast Track Initiative is a venture capital firm with an exclusive focus on life sciences and healthcare services. ## Matrix Partners China - Type: VC Fund - Location: Beijing, Beijing, China - Relevant deals: 16 - Stages: Series A, Series B, Series C - Focus: Health Care, Biotechnology, Software Matrix Partners China builds long-term relationships with entrepreneurs and helps them build significant, industry-leading companies.Since its inception in 1977, Matrix Partners China has made hundreds of investments and played an active role in the development of many successful businesses, 50 of which went on to IPO, and 75 of which have goneon to profitable M&A events. The firm consistently ranks in the top venture firms in terms of returns to its investors.Matrix Partners China combines local knowledge with global experience and vision. Its team consists of both former entrepreneurs and experienced investors. Its past successes include Focus Media, Eachnet, and Baidu, among others. The company invests across multiple sectors and stages. ## IDG Capital - Type: VC Fund - Location: Beijing, Beijing, China - Relevant deals: 16 - Stages: Series A, Series B, Series C - Focus: Software, Internet, E-Commerce IDG Capital is a global investment firm partnering with founders to build enduring businesses through capital, expertise, and long-term support. ## BioTrack Capital - Type: VC Fund - Location: Shanghai, Shanghai, China - Relevant deals: 15 - Stages: Series A, Series B, Seed - Focus: Biotechnology, Health Care, Medical BioTrack Capital invests in early and growth stage companies within life sciences, healthcare technology, biotechnology and related high-tech sectors, providing capital and investment support for innovation. The firm evaluates scientific and commercial potential of ventures and structures financings aimed at advancing technologies from earlyresearch to market engagement. Its activities include sourcing opportunities, conducting due diligence, and working with founders and management teams to align growth strategies with investor objectives. BioTrack Capital also participates in funding rounds alongside co-investors to support development of novel healthcare and tech solutions. The company engages with portfolio companies through strategic interaction and monitoring of progress toward business milestones. ## Dalton Venture - Type: VC Fund - Location: Shanghai, Shanghai, China - Relevant deals: 15 - Stages: Seed, Series A, Series B - Focus: Health Care, Medical, Biotechnology Dalton Venture is a fund management company that specializes in early stage investment and industrial mergers and acquisitions in the field of big health. ## Legend Star - Type: VC Fund - Location: Beijing, Beijing, China - Relevant deals: 15 - Stages: Series A, Seed, Angel - Focus: Health Care, Medical, Biotechnology Legend Star helps entrepreneurs create great businesses through investments, CEO training sessions and an entrepreneurs alliance.Since 2008, Legend Star has incubated and invested in nearly 600 companies and is deeply integrated in the Chinese entrepreneurial ecosystem.Legend Star is the independent early-stage investment arm of LegendHoldings. Legend Holdings is the parent company of Lenovo, Raycom Real Estate, Joyvio Agribusiness and a large range of fast-growing Chinese companies. ## ZSVC - Type: VC Fund - Location: Beijing, Beijing, China - Relevant deals: 15 - Stages: Series A, Seed, Series B - Focus: Manufacturing, Medical, Health Care ZSVC is a Chinese venture capital firm specialized in seed and early stage investments. ## Share Capital - Type: VC Fund - Location: Shenzhen, Guangdong, China - Relevant deals: 15 - Stages: Series A, Series B, Seed - Focus: Health Care, Medical, Biotechnology Share Capital is a venture capital firm specializing in seed, start-up, early, middle, growth capital, and Pre-IPO investments. it primarily invests in big living, medical healthcare, and internet innovation. In medical healthcare, it seeks to invests in pharmaceuticals, innovative equipment, biotechnology, diagnostic testing equipment andreagents, anti-infectives, drug discovery, medical health service, mobile medical services, and informatization. ## Northern Light Venture Capital - Type: VC Fund - Location: Beijing, Beijing, China - Relevant deals: 15 - Stages: Series A, Series B, Seed - Focus: Health Care, Medical, Biotechnology Supporting the next generation of entpreneurs in enterprise, healthcare, and consumer with disruptive potential. ## Jan Hammer - Type: Angel - Location: London, England, United Kingdom - Relevant deals: 14 - Stages: Series A, Series B, Seed - Focus: Health Care, Medical, Medical Device Jan Hammer is the partner at Index and the Board observer of Harmonic. Jan attended Oxford University. ## Cowin Capital - Type: VC Fund - Location: Shenzhen, Guangdong, China - Relevant deals: 14 - Stages: Series A, Series B, Seed - Focus: Manufacturing, Health Care, Biotechnology Cowin Capital is a private placement equity investment company focusing on investing in a pioneering enterprise on a long-term basis. It has 18 years of experience in capital management, whose capital management scale was among the front rank, which invested more than 300 companies, of which 60 more became public companies, and 150 moresuccessfully exit.The company was successfully listed on NEEQ, with code 832793, as the third listed famous domestic venture capital institution in NEEQ. It is committed to supporting the growth of small and medium enterprises, continue to launch high-quality listed companies in China Capital Market. ## CDH Investments - Type: VC Fund - Location: Kowloon City, Kowloon, Hong Kong - Relevant deals: 14 - Stages: Series A, Series B, Series C - Focus: Manufacturing, Health Care, Biotechnology CDH Investments is an international alternative asset fund manager with over $27 billion of assets under management. CDH Investments was established in 2002 by the former private equity group of China International Capital Corporation and is managed by an experienced team of senior private equity professionals who have worked together for manyyears focusing all their professional time on investing in China. CDH has consistently delivered superior returns relative to industry peers and is well positioned to continue to generate superior returns due to the team's proven investment experience and expertise investing in China. ## SMBC Venture Capital - Type: VC Fund - Location: Tokyo, Tokyo, Japan - Relevant deals: 13 - Stages: Series A, Series B - Focus: Information Technology, Health Care, Software Sumitomo Mitsui Banking Corporation (SMBC) and its group companies offer a broad range of financial services centered on banking. They are also engaged in the leasing, securities, credit card, investment, mortgage securitization, venture capital and other credit related businesses. The following lists the activities of SMBC, its subsidiaries andaffiliates in the various business segments. ## Highlight Capital - Type: VC Fund - Location: Nanjin, Jiangsu, China - Relevant deals: 13 - Stages: Series A, Series B, Seed - Focus: Health Care, Medical, Biotechnology Highlight Capital is an investment firm dedicated to support healthcare companies to generate robust and sustained growth prospect. ## UTEC - The University of Tokyo Edge Capital Partners - Type: VC Fund - Location: Tokyo, Tokyo, Japan - Relevant deals: 12 - Stages: Seed, Series A - Focus: Health Care, Biotechnology, Medical UTEC-The University of Tokyo Edge Capital Partners Co., Ltd.. UTEC is a seed/early stage technology focused venture capital firm associated with The University of Tokyo. ## Goldport Capital - Type: VC Fund - Location: Shenzhen, Guangdong, China - Relevant deals: 12 - Stages: Series A, Seed, Angel - Focus: Manufacturing, Medical, Semiconductor Goldport Capital is a Shenzhen-based asset management company. ## Taiyu Investment - Type: VC Fund - Relevant deals: 12 - Stages: Seed, Series A, Angel - Focus: Medical, Health Care, Biotechnology Taiyu Investment is an investment firm. ## Keio Innovation Initiative - Type: VC Fund - Location: Tokyo, Tokyo, Japan - Relevant deals: 12 - Stages: Series A, Seed - Focus: Health Care, Medical, Biotechnology Keio Innovation Initiative (KII) is a venture capital established by Keio University. In order to make more effective use of the research results of Keio University, we aim to contribute to the development of society by creating investment for venture companies that utilize research results and creating new industries.The key to thinking aboutJapan's future growth strategy is to utilize advanced research results of the university. In addition to GDP, in addition to GDP, Japan is the world's third largest R & D exporter in R & D expenses, but as the low growth rate shows, it has a problem in investment efficiency in research and development. There are also reports on the entrepreneurial spirit that is indispensable for creating new industries, with the lowest entrepreneurial activity rate among developed countries. ## Sherpa Healthcare Partners - Type: VC Fund - Location: Beijing, Beijing, China - Relevant deals: 12 - Stages: Series A, Series B, Series C - Focus: Biotechnology, Health Care, Medical Sherpa Venture Capital is an investment firm that focuses on the investment and cultivation of the Pharmaceutical and Biotech industry. It also specializes in the investment and management of sector leaders and innovators within the Pharma, GeneTech, MedTech, Medical services, and various sub-sectors, where they have established robust portfoliosources, lasting value-adding cooperations and relationships, as well as mature all-cycle services with key resources. It was founded in 2018 and is headquartered in Beijing, China. ## UntroD Capital - Type: VC Fund - Location: Sumida, Tokyo, Japan - Relevant deals: 11 - Stages: Seed, Series A - Focus: Manufacturing, Biotechnology, Medical UntroD Capital is an R&D-based innovative technology that specializes in social implementation. ## Sunland Fund - Type: VC Fund - Location: Shanghai, Shanghai, China - Relevant deals: 11 - Stages: Series B, Series A, Seed - Focus: Medical, Health Care, Medical Device Shanlan Capital is a professional fund focused on early and growing health care industry investments with offices in Shanghai and Beijing, focusing on biomedical and medical devices (in vitro diagnostics and gene technology, minimally invasive interventions, implantable devices, minimally invasive High-growth segments such as surgical instrumentsand medical robots, and medical services. It has invested in 15 medical star companies such as Guoke Hengtai, Ricky Surgery, Jingyi Medical, Haipulos, Langhe Medical, etc. The core team of Shanlan Capital is the founder of the medical industry listed company, professional financial and strategic investment. Composition of people, in strategy formulation, talent introduction, technology research and development, market camp.. ## Lenovo Capital and Incubator Group (LCIG) - Type: VC Fund - Location: Beijing, Beijing, China - Relevant deals: 11 - Stages: Series A, Seed, Series B - Focus: Manufacturing, Artificial Intelligence, Software Lenovo Capital and Incubator Group is an accelerator and venture capital firm. ## Cenova - Type: VC Fund - Location: Shanghai, Shanghai, China - Relevant deals: 11 - Stages: Series A, Series B, Series C - Focus: Health Care, Medical, Biotechnology Cenova Capital is one of the earliest healthcare dedicated funds in China founded in 2010 by Dr Jun WU and is one of the earliest investors in private healthcare services and digital health, with helps to facilitate the transformation of healthcare in China from an exclusively state-owned system to a more efficient, market-oriented system. CenovaCapital is healthcare funds dedicated to early and growth-stage investments in the life sciences and healthcare sector in China. Since inception in 2010, Cenova now has five funds under management with investments in over 50 companies in healthcare services, pharmaceuticals, medical devices and digital heath. Cenova's investors are mainly large domestic and international institutional investors including Asian sovereign wealth funds, government institutions, insurance and financial institutions and multinational companies. ## JAFCO - Type: VC Fund - Location: Tokyo, Tokyo, Japan - Relevant deals: 11 - Stages: Series A, Series B - Focus: Information Technology, Software, Artificial Intelligence Since its founding in 1973, JAFCO has always worked with leading-edge entrepreneurs. The total capital commitments of its investment funds in Japan and overseas have exceeded 1 trillion yen and the number of portfolio IPOs to date has reached over 1,000. In addition to venture investment, JAFCO also carries out buyout investment and commit to thecreations of innovative technologies and services worldwide. As entrepreneurs’ closest partner in bringing their visions to life, JAFCO provides support in areas of HR, marketing/ sales, and back-office operations, in addition to providing financing. ## Oriza Seed Capital (Oriza Yuandian) - Type: VC Fund - Location: Suzhou, Jiangsu, China - Relevant deals: 11 - Stages: Series A, Seed, Angel - Focus: Manufacturing, Health Care, Biotechnology Oriza Seed Venture Capital, located in Suzhou Industrial Park, is held by Suzhou Oriza Holdings Ltd. Oriza Seed is a market-oriented investment platform. It looks for investment opportunities among early-stage and growth-stage enterprises in the fields of Healthcare and TMT. Oriza Seed has ample resources and experiences investing in the healthcarefield. By late March 2016, Oriza Seed has invested in more than 50 healthcare companies, including Ascentage Pharma, Innovent Biologics, and SceneRay Corporation. ## Shunwei Capital - Type: VC Fund - Location: Beijing, Beijing, China - Relevant deals: 10 - Stages: Series A, Series B, Series C - Focus: Manufacturing, Software, Internet Shunwei Capital is a venture capital fund that focuses on early to mid-stage investments in local internet industry. It specializes in incubation, startups, early to mid-stage, and growth capital investments. It seeks to invest in the technology, media, telecommunications, high technology, new media, games, internet finance, and rural area internetsectors. Their investors include sovereign wealth funds, fund of funds, university endowment funds, and family offices. ## EFung Capital - Type: VC Fund - Location: Shenzhen, Guangdong, China - Relevant deals: 10 - Stages: Series A, Series B, Series C - Focus: Health Care, Biotechnology, Medical Shenzhen EFUNG Investment Management Enterprise L. P. is one of China's earliest institutions investing in professional biomedical industries. Their strong research team and great investment returns made us won 'The Most Pioneering VC Institution” 'The Most Dynamic Pharmaceutical VC Institution in China' and 'The Top Ten VCInstitutions in Shenzhen'. With this influence, EFUNG has drawn a lot of attention from the medical and life science industry. And it is interviewed by Nature, which is the most authoritative science magazine in the world. Over a decade of years, they have been focusing on the medical and health industry, especially the VC and PE investment business of novel drugs and high-end medical devices. The mission of EFUNG is to drive the industrialization of medical researches by capital and to gain rich returns to investors. EFUNG has deeply screened and invested in more than 20 domestic and international premium enterprises, such as Chipscreen Biosciences, Frontier Biotechnologies, Ascentage Pharma, Lifotronic, Aridis Pharmaceuticals, and Centrexion. ## Nissay Capital - Type: VC Fund - Location: Tokyo, Tokyo, Japan - Relevant deals: 10 - Stages: Seed, Series A - Focus: Health Care, Information Technology, Medical Nissay Capital is a venture capital Company specializing in seed, start-up, growth capital, middle stage, and later stage investment. ## Long Hill Capital - Type: VC Fund - Location: Shanghai, Shanghai, China - Relevant deals: 10 - Stages: Series A, Series B, Angel - Focus: Medical, Health Care, Training Long Hill Capital is a next generation thesis-driven venture capital firm. We invest in technology-enabled healthcare and consumer services companies which seek to massively improve health and quality of life for every Chinese.Since 2005 the founding team of Long Hill Capital have led the China investing practice for New Enterprise Associates(NEA), a global investment firm with over $17 billion in committed capital. They are joined by an experienced team of investment and operations professionals from such firms as Matrix Partners China and Morningside VC. Together the Long Hill Capital team have over 30 years of China venture capital experience and over 15 years of senior operating experience at some of China’s most successful technology and healthcare companies including Alibaba, Huawei and Ping’an Good Doctor.Over the course of their venture capital careers, the Long Hill Capital team have invested in such industry leading companies as CITIC Pharmaceutical, WeDoctor, Hygeia Medical Services, GST Clinics, LineKong, LianLian Pay, Ele.Me, TheBeastShop and more. ## Shenzhen Capital Group - Type: VC Fund - Location: Shenzhen, Guangdong, China - Relevant deals: 10 - Stages: Series A, Series B, Series C - Focus: Manufacturing, Health Care, Software Shenzhen Capital Group Co., Ltd (“SCGC”) is a limited venture capital company established by the Shenzhen Government in 1999. Since its establishment, SCGC has focused on cultivating national industries, shaping national brands, promoting economic transformation, and emerging industries developing. SCGC has registered capital of 5.42 billion RMB,and a total AUM of 338.99 billion RMB. SCGC primarily invests in SMEs, innovative high-tech enterprises, enterprises in emerging industries, and enterprises in start-up period, growth period and in transformation, covering industries supported by national policies, including IT, internet, new media, biopharma, new energy, environmental protection, chemical engineering, new material, high-end equipment manufacturing, consumption goods, modern service, etc. By the end of April 2019, SCGC ranked the first based on the number of portfolio companies and the number of listed portfolio companies: 994 portfolio companies, investments totaling 43.9 billion RMB, 145 of which have been listed in 16 capital markets worldwide. ## Hillhouse Investment - Type: VC Fund - Location: Changyang, Beijing, China - Relevant deals: 9 - Stages: Series B, Series A, Series C - Focus: Biotechnology, Health Care, Software Founded in 2005, Hillhouse is a leading global investment management firm, active across public equity, private equity, real estate and private credit. The firm invests over a long-term horizon and partners with exceptional entrepreneurs to deliver sustainable value creation for quality companies.Hillhouse is a full life-cycle private equityfirm, investing for the long term across opportunities in the healthcare, business services, consumer, and industrials sectors. The firm manages capital on behalf of global institutions such as non-profit foundations, endowments, and pensions. ## CD Capital - Type: VC Fund - Location: Shanghai, Shanghai, China - Relevant deals: 9 - Stages: Series A, Series B, Seed - Focus: Health Care, Biotechnology, Medical Device CD Capital is a venture capital firm specialized in life sciences and medical technology. They are currently managing both RMB and USD funds with total size of $600M. CD Capital is operated by a professional team with diversified and profound industry backgrounds. They have made over 40 investments with high growth potential and earned a reputationas a premier venture capital firm with main focus on China healthcare industry. With broad network around China and the world, they have been able to seize the global trend, capture investment opportunities as well as help to define the future for China healthcare industry. Ultimately, they strive to grow best-in-class companies and deliver solid financial return to their investors. ## BIOCHING CAPITAL - Type: VC Fund - Location: Longgang, Guangdong, China - Relevant deals: 9 - Stages: Angel, Series A, Seed - Focus: Medical Device, Medical, Biotechnology BIOCHING CAPITAL is an investment management firm. ## Gaorong Capital - Type: VC Fund - Location: Wangjing, Beijing, China - Relevant deals: 9 - Stages: Series A, Series B, Seed - Focus: Information Technology, Software, Artificial Intelligence Gaorong Capital is a venture capital firm that focuses on early and growth stage investments in TMT, including AI and frontier technologies. ## Huagai Capital - Type: VC Fund - Location: Beijing, Beijing, China - Relevant deals: 9 - Stages: Series A, Series B, Angel - Focus: Health Care, Biotechnology, Medical Huagai Capital is a private equity investment firm that invests in start-up or growth companies in the areas of healthcare, TMT, and culture. ## Trustbridge Partners - Type: VC Fund - Location: Boston, Massachusetts, United States - Relevant deals: 9 - Stages: Series A, Series B, Series C - Focus: Education, Health Care, Medical Trustbridge Partners is a mission-driven growth equity firm founded in 2006 with approximately $8 billion under management.